Trial Evaluating Maintenance Chemotherapy for Metastatic Nasopharyngeal Carcinoma
Status:
Unknown status
Trial end date:
2018-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine the efficacy of maintenance chemotherapy for the
treatment of metastatic nasopharyngeal carcinoma. Participants will be randomized to 3 arms.
Arm 1, control group, participants will receive only 4-8 cycles of conventional chemotherapy;
arm 2, participants will receive 6 cycles of maintenance chemotherapy after conventional
chemotherapy; arm 3, experiment arm, after conventional chemotherapy, participants will
receive maintenance chemotherapy until disease progression or intolerable toxicities.
Phase:
Phase 3
Details
Lead Sponsor:
Shanghai Proton and Heavy Ion Center
Collaborators:
Beijing Cancer Hospital Cancer Hospital of Guangxi Medical University Eye & ENT Hospital of Fudan University First Affiliated Hospital of Fujian Medical University Fudan University Jiangxi Provincial Cancer Hospital National Cancer Centre, Singapore People's Hospital of Guangxi Taichung Veterans General Hospital The First Affiliated Hospital of Xiamen University Tongji Hospital West China Hospital